Recent Developments

BioTelemetry Inc. announced the acquisition of LifeWatch AG in a deal valued at about $280 million. With this buyout, BioTelemetry enhanced its position in the wireless medicine space, enlarging its product profile and customer base in the cardiac monitoring and diagnostic services space. In completing the acquisition and securing its position as market leader in remote cardiac monitoring and diagnostic services, BioTelemetry needs to focus on combining both strengths of these two companies at the same time. The Company will use its new scale to advance device innovation and expand into other chronic care sectors, leveraging the unique capabilities of remote monitoring to enhance the delivery of care. Going forward, BioTelemetry has been gaining prominence of late on expanded payer coverage and with the introduction of innovative products. Furthermore, BioTelemetry had a strong financial position with more than $25 million in cash. The company posted stellar first-quarter revenue of $56 million, up 15% on a year-over-year basis.

BioTelemetry, Inc., incorporated on April 12, 2013, provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates through three segments: Healthcare, Technology and Research. The company is focused on the delivery of health information to improve quality of life and reduce cost of care. Whereas, LifeWatch AG, headquartered in Zug, Switzerland is listed amongst the SIX Swiss Exchange (LIFE), is a leading healthcare solutions company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services.

To know more: https://www.marketdataforecast.com/market-reports/cardiovascular-monitoring-and-diagnostic-devices-market-222/



Market Segmentations

Market Data Forecast published a report named The Market Value was worth USD 2096.77 million in 2018 and estimated to be growing at a CAGR of 7.11%, to reach USD 2956.26 million by 2023.
Report segmented as:
Product:

· ECG systems

· Holter Monitors

· Event Monitors

· Implantable loop recorders

· ECG management systems

Based on product, ECG systems accounted for the largest share in the market and expected to maintain its stronghold in the market during the forecast period due to widespread availability and increasing preference for these devices in both developed and developing regions.

Geographical Segmentation:

Based on geography, global market for Cardiovascular Monitoring And Diagnostic Devices Market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America is the largest market for cardiovascular diagnostic and monitoring devices market and is expected to sustain its strong share owing to its favorable reimbursement policies and high awareness about available diagnosis and treatment methods among patients and physicians. Asia-Pacific is estimated to be the fastest growing region during the forecast period due to raising awareness about the effectiveness of accessible devices in successfully curing several cardiovascular conditions and increasing healthcare spending.

Key market players:

· Siemens Healthcare

· Biotelemetry Inc.

· Boston Scientific Corporation

· St. Jude Medical, Inc.

· Nihon Kohden Corporation

View sample and decide:

https://www.marketdataforecast.com/market-reports/cardiovascular-monitoring-and-diagnostic-devices-market-222/request-sample

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.